The Vagus Nerve: A Tonic Inhibitory Influence Associated With Inflammatory Bowel Disease in a Murine Model

Gastroenterology

Volumn 131, Issue 4, 2006, Pages 1122-1130

  Ghia, Jean Eric ^a   Blennerhassett, Patricia ^a   Kumar Ondiveeran, Harry ^a   Verdu, Elena F ^a   Collins, Stephen M ^a  

^a MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; COLONY STIMULATING FACTOR; DEXTRAN SULFATE; HAPTEN; HEXAMETHONIUM; INTERLEUKIN 1BETA; INTERLEUKIN 6; MYELOPEROXIDASE; NICOTINE; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COLITIS; CONTROLLED STUDY; DISEASE ACTIVITY; ENTERITIS; ENZYME ACTIVITY; HISTOPATHOLOGY; MACROPHAGE; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PYLOROPLASTY; VAGOTOMY; VAGUS NERVE;

EID: 33749321161     PISSN: 00165085     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.gastro.2006.08.016     Document Type: Article

References (48)

1. Rutgeerts P. Protagonist: Crohn's disease recurrence can be prevented after ileal resection. Gut 51 (2002) 152-153
2. Fiocchi C. Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115 (1998) 182-205
3. Papadakis K.A., and Targan S.R. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med 51 (2000) 289-298
4. Sartor R.B. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 92 (1997) 5S-11S
5. Podolsky D.K. Inflammatory bowel disease (1). N Engl J Med 325 (1991) 928-937
6. Atreya R., Mudter J., Finotto S., Mullberg J., Jostock T., Wirtz S., Schutz M., Bartsch B., Holtmann M., Becker C., Strand D., Czaja J., Schlaak J.F., Lehr H.A., Autschbach F., Schurmann G., Nishimoto N., Yoshizaki K., Ito H., Kishimoto T., Galle P.R., Rose-John S., and Neurath M.F. Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in Crohn disease and experimental colitis in vivo. Nat Med 6 (2000) 583-588
7. Ferretti M., Casini-Raggi V., Pizarro T.T., Eisenberg S.P., Nast C.C., and Cominelli F. Neutralization of endogenous IL-1 receptor antagonist exacerbates and prolongs inflammation in rabbit immune colitis. J Clin Invest 94 (1994) 449-453
8. Matsunaga K., Klein T.W., Friedman H., and Yamamoto Y. Involvement of nicotinic acetylcholine receptors in suppression of antimicrobial activity and cytokine responses of alveolar macrophages to Legionella pneumophila infection by nicotine. J Immunol 167 (2001) 6518-6524
9. Dvorak A.M., Onderdonk A.B., McLeod R.S., Monahan-Earley R.A., Cullen J., Antonioli D.A., Blair J.E., Morgan E.S., Cisneros R.L., Estrella P., et al. Axonal necrosis of enteric autonomic nerves in continent ileal pouches. Possible implications for pathogenesis of Crohn's disease. Ann Surg 217 (1993) 260-271
10. Lindgren S., Lilja B., Rosen I., and Sundkvist G. Disturbed autonomic nerve function in patients with Crohn's disease. Scand J Gastroenterol 26 (1991) 361-366
11. McCafferty D.M., Wallace J.L., and Sharkey K.A. Effects of chemical sympathectomy and sensory nerve ablation on experimental colitis in the rat. Am J Physiol 272 (1997) G272-G280
12. Eliakim R., Karmeli F., Rachmilewitz D., Cohen P., and Fich A. Effect of chronic nicotine administration on trinitrobenzene sulphonic acid-induced colitis. Eur J Gastroenterol Hepatol 10 (1998) 1013-1019
13. Blalock J.E. Harnessing a neural-immune circuit to control inflammation and shock. J Exp Med 195 (2002) F25-F28
14. Tracey K.J. The inflammatory reflex. Nature 420 (2002) 853-859
15. Mazelin L., Theodorou V., More J., Fioramonti J., and Bueno L. Protective role of vagal afferents in experimentally-induced colitis in rats. J Auton Nerv Syst 73 (1998) 38-45
16. van Westerloo D.J., Giebelen I.A., Florquin S., Daalhuisen J., Bruno M.J., de Vos A.F., Tracey K.J., and van der Poll T. The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. J Infect Dis 191 (2005) 2138-2148
17. Wang H., Liao H., Ochani M., Justiniani M., Lin X., Yang L., Al-Abed Y., Metz C., Miller E.J., Tracey K.J., and Ulloa L. Cholinergic agonists inhibit HMGB1 release and improve survival in experimental sepsis. Nat Med 10 (2004) 1216-1221
18. Wang H., Yu M., Ochani M., Amella C.A., Tanovic M., Susarla S., Li J.H., Yang H., Ulloa L., Al-Abed Y., Czura C.J., and Tracey K.J. Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature 421 (2003) 384-388
19. Borovikova L.V., Ivanova S., Zhang M., Yang H., Botchkina G.I., Watkins L.R., Wang H., Abumrad N., Eaton J.W., and Tracey K.J. Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405 (2000) 458-462
20. Mahida Y.R., Wu K., and Jewell D.P. Enhanced production of interleukin 1-beta by mononuclear cells isolated from mucosa with active ulcerative colitis of Crohn's disease. Gut 30 (1989) 835-838
21. Woywodt A., Ludwig D., Neustock P., Kruse A., Schwarting K., Jantschek G., Kirchner H., and Stange E.F. Mucosal cytokine expression, cellular markers and adhesion molecules in inflammatory bowel disease. Eur J Gastroenterol Hepatol 11 (1999) 267-276
22. Elson C.O., Sartor R.B., Tennyson G.S., and Riddell R.H. Experimental models of inflammatory bowel disease. Gastroenterology 109 (1995) 1344-1367
23. Okayasu I., Hatakeyama S., Yamada M., Ohkusa T., Inagaki Y., and Nakaya R. A novel method in the induction of reliable experimental acute and chronic ulcerative colitis in mice. Gastroenterology 98 (1990) 694-702
24. Sturiale S., Barbara G., Qiu B., Figini M., Geppetti P., Gerard N., Gerard C., Grady E.F., Bunnett N.W., and Collins S.M. Neutral endopeptidase (EC 3.4.24.11) terminates colitis by degrading substance P. Proc Natl Acad Sci U S A 96 (1999) 11653-11658
25. Ritter R.C., and Ladenheim E.E. Capsaicin pretreatment attenuates suppression of food intake by cholecystokinin. Am J Physiol 248 (1985) R501-R504
26. Verdu E.F., Deng Y., Bercik P., and Collins S.M. Modulatory effects of estrogen in two murine models of experimental colitis. Am J Physiol 283 (2002) G27-G36
27. Galeazzi F., Blennerhassett P.A., Qiu B., O'Byrne P.M., and Collins S.M. Cigarette smoke aggravates experimental colitis in rats. Gastroenterology 117 (1999) 877-883
28. Cooper H.S., Murthy S.N., Shah R.S., and Sedergran D.J. Clinicopathologic study of dextran sulfate sodium experimental murine colitis. Lab Invest 69 (1993) 238-249
29. Szalai A.J., van Ginkel F.W., Dalrymple S.A., Murray R., McGhee J.R., and Volanakis J.E. Testosterone and IL-6 requirements for human C-reactive protein gene expression in transgenic mice. J Immunol 160 (1998) 5294-5299
30. Appleyard C.B., and Wallace J.L. Reactivation of hapten-induced colitis and its prevention by anti-inflammatory drugs. Am J Physiol 269 (1995) G119-G125
31. Boughton-Smith N.K., Wallace J.L., and Whittle B.J. Relationship between arachidonic acid metabolism, myeloperoxidase activity and leukocyte infiltration in a rat model of inflammatory bowel disease. Agents Actions 25 (1988) 115-123
32. Bradley P.P., Priebat D.A., Christensen R.D., and Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 78 (1982) 206-209
33. Dieleman L.A., Ridwan B.U., Tennyson G.S., Beagley K.W., Bucy R.P., and Elson C.O. Dextran sulfate sodium-induced colitis occurs in severe combined immunodeficient mice. Gastroenterology 107 (1994) 1643-1652
34. Saunders P.R., Hanssen N.P., and Perdue M.H. Cholinergic nerves mediate stress-induced intestinal transport abnormalities in Wistar-Kyoto rats. Am J Physiol 273 (1997) G486-G490
35. Greenwood B., and Mantle M. Mucin and protein release in the rabbit jejunum: effects of bethanechol and vagal nerve stimulation. Gastroenterology 103 (1992) 496-505
36. Bernik T.R., Friedman S.G., Ochani M., DiRaimo R., Susarla S., Czura C.J., and Tracey K.J. Cholinergic antiinflammatory pathway inhibition of tumor necrosis factor during ischemia reperfusion. J Vasc Surg 36 (2002) 1231-1236
37. Wiktor-Jedrzejczak W., Ratajczak M.Z., Ptasznik A., Sell K.W., Ahmed-Ansari A., and Ostertag W. CSF-1 deficiency in the op/op mouse has differential effects on macrophage populations and differentiation stages. Exp Hematol 20 (1992) 1004-1010
38. Wiktor-Jedrzejczak W., Bartocci A., Ferrante Jr. A.W., Ahmed-Ansari A., Sell K.W., Pollard J.W., and Stanley E.R. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A 87 (1990) 4828-4832
39. Yoshida H., Hayashi S., Kunisada T., Ogawa M., Nishikawa S., Okamura H., Sudo T., and Shultz L.D. The murine mutation osteopetrosis is in the coding region of the macrophage colony stimulating factor gene. Nature 345 (1990) 442-444
40. Antonica A., Ayroldi E., Magni F., and Paolocci N. Lymphocyte traffic changes induced by monolateral vagal denervation in mouse thymus and peripheral lymphoid organs. J Neuroimmunol 64 (1996) 115-122
41. Gottwald T.P., Lhotak S., and Stead R.H. Effects of subdiaphragmatic vagotomy on mucosal mast cell densities in stomach and jejunum of rats. Adv Exp Med Biol 371A (1995) 303-306
42. Dapoigny M., Cowles V.E., Zhu Y.R., and Condon R.E. Vagal influence on colonic motor activity in conscious nonhuman primates. Am J Physiol 262 (1992) G231-G236
43. Pahlin P.E., and Kewenter J. The vagal control of the ileo-cecal sphincter in the cat. Acta Physiol Scand 96 (1976) 433-442
44. Nugent F.W., and Roy M.A. Duodenal Crohn's disease: an analysis of 89 cases. Am J Gastroenterol 84 (1989) 249-254
45. Lindgren S., Stewenius J., Sjolund K., Lilja B., and Sundkvist G. Autonomic vagal nerve dysfunction in patients with ulcerative colitis. Scand J Gastroenterol 28 (1993) 638-642
46. Cosnes J. Tobacco and IBD: relevance in the understanding of disease mechanisms and clinical practice. Best Pract Res Clin Gastroenterol 18 (2004) 481-496
47. de Jonge W.J., van der Zanden E.P., The F.O., Bijlsma M.F., van Westerloo D.J., Bennink R.J., Berthoud H.R., Uematsu S., Akira S., van den Wijngaard R.M., and Boeckxstaens G.E. Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6 (2005) 844-851
48. Luyer M.D., Greve J.W., Hadfoune M., Jacobs J.A., Dejong C.H., and Buurman W.A. Nutritional stimulation of cholecystokinin receptors inhibits inflammation via the vagus nerve. J Exp Med 202 (2005) 1023-1029